Bacterial vaginosis - A disturbed bacterial flora and treatment enigma

APMIS

Volumn 113, Issue 5, 2005, Pages 305-316

  Larsson, P G ^a,b   Forsum, U ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b Kärnsjukhuset ^*  (Sweden)

Author keywords

Bacterial vaginosis; Clinical outcome; Review; Study design; Treatment

Indexed keywords

BUFFER; CLINDAMYCIN; LACTIC ACID; METRONIDAZOLE; MICONAZOLE NITRATE; NYSTATIN; PLACEBO; PROBIOTIC AGENT;

BACTERIAL FLORA; BACTERIAL IMMUNITY; BACTERIAL OVERGROWTH; CONSENSUS; FOLLOW UP; GEL; HOST PARASITE INTERACTION; HUMAN; LACTOBACILLUS; PREGNANCY; PRIORITY JOURNAL; REVIEW; TIME; TREATMENT OUTCOME; VAGINITIS;

ANTI-BACTERIAL AGENTS; CLINICAL TRIALS; FEMALE; HUMANS; PREGNANCY; RECURRENCE; SYNDROME; VAGINOSIS, BACTERIAL;

EID: 21344455107     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2005.apm_113501.x     Document Type: Review

References (100)

1. Larsson PG. Treatment of bacterial vaginosis. Int J STD AIDS 1992;3:239-47.
2. Forsum U, Hallen A, Larsson PG. Bacterial vaginosis - a laboratory and clinical diagnostics enigma. Review II. APMIS 2005;113:153-61.
3. Lossick JG. Treatment of sexually transmitted vaginosis/vaginitis. Rev Infect Dis 1990:12 Suppl 6:S665-81.
4. Lugo-Miro VI, Green M, Mazur L. Comparison of different metronidazole therapeutic regimens for bacterial vaginosis. A meta-analysis. JAMA 1992;268:92-5.
5. Berrebi A. [Antibiotics and bacterial vaginosis]. Rev Fr Gynecol Obstet 1993;88:215-7.
6. Sweet RL. New approaches for the treatment of bacterial vaginosis. Am J Obstet Gynecol 1993;169:479-82.
7. Ledger WJ. Historical review of the treatment of bacterial vaginosis. Am J Obstet Gynecol 1993;169:474-8.
8. Neri A, Rabinerson D, Kaplan B. Bacterial vaginosis: drugs versus alternative treatment. Obstet Gynecol Surv 1994;49:809-13.
9. Schlicht JR. Treatment of bacterial vaginosis. Ann Pharmacother 1994;28:483-7.
10. Joesoef MR, Schmid GP. Bacterial vaginosis: review of treatment options and potential clinical indications for therapy. Clin Infect Dis 1995;20 Suppl 1:S72-9.
11. Carr PL, Felsenstein D, Friedman RH. Evaluation and management of vaginitis. J Gen Intern Med 1998;13:335-46.
12. Joesoef MR, Schmid GP, Hillier SL. Bacterial vaginosis: review of treatment options and potential clinical indications for therapy. Clin Infect Dis 1999;28 Suppl 1:S57-65.
13. Larsson PG. Bacterial vaginosis treatment evaluation before one month is not accurate. Am J Obstet Gynecol 1995;172:1638-9.
14. Chaithongwongwatthana S, Limpongsanurak S, Sitthi-Amorn C. Single hydrogen peroxide vaginal douching versus single-dose oral metronidazole for the treatment of bacterial vaginosis: a randomized controlled trial. J Med Assoc Thai 2003;86 Suppl 2:S379-84.
15. Baloglu E, Ozyazici M, Baloglu A, Ova L. A randomized controlled trial of a new ovule formulation of ornidazole for the treatment of bacterial vaginosis. J Clin Pharm Ther 2003;28:131-6.
16. Ballagh SA, Baker JM, Henry DM, Archer DF. Safety of single daily use for one week of C31G HEC gel in women. Contraception 2002;66:369-75.
17. Wewalka G, Stary A, Bosse B, Duerr HE, Reimer K. Efficacy of povidone-iodine vaginal suppositories in the treatment of bacterial vaginosis. Dermatology 2002;204 Suppl 1:79-85.
18. Jerve F, Berdal TB, Bohman P, Cappelen SC, Evjen OK, Gjönnaess H. Metronidazole in the treatment of non-specific vaginitis (NSV). Br J Vener Dis 1984;60:171-4.
19. Blackwell AL, Fox AR, Phillips I, Barlow D. Anaerobic vaginosis (non-specific vaginitis): clinical, microbiological, and therapeutic findings. Lancet 1983;ii:1379-82.
20. Larsson PG, Bergman B, Forsum U, Pahlson C. Treatment of bacterial vaginosis in women with vaginal bleeding complications or discharge and harboring Mobiluncus. Gynecol Obstet Invest 1990;29:296-300.
21. Livengood CH 3rd, Thomason JL, Hill GB. Bacterial vaginosis: treatment with topical intravaginal clindamycin phosphate. Obstet Gynecol 1990;76:118-23.
22. Hillier S, Krohn MA, Watts DH, Wolner-Hanssen P, Eschenbach D. Microbiologic efficacy of intravaginal clindamycin cream for the treatment of bacterial vaginosis. Obstet Gynecol 1990;76:407-13.
23. Schmitt C, Sobel JD, Meriwether C. Bacterial vaginosis: treatment with clindamycin cream versus oral metronidazole. Obstet Gynecol 1992;79:1020-3.
24. Andres FJ, Parker R, Hosein I, Benrubi GI. Clindamycin vaginal cream versus oral metronidazole in the treatment of bacterial vaginosis: a prospective double-blind clinical trial. South Med J 1992;85:1077-80.
25. Stein GE, Christensen SL, Mummaw NL, Soper DE. Placebo-controlled trial of intravaginal clindamycin 2% cream for the treatment of bacterial vaginosis. Ann Pharmacother 1993;27:1343-5.
26. Fischbach F, Petersen EE, Weissenbacher ER, Martius J, Hosmann J, Mayer H. Efficacy of clindamycin vaginal cream versus oral metronidazole in the treatment of bacterial vaginosis. Obstet Gynecol 1993;82:405-10.
27. Dhar J, Arya OP, Timmins DJ, Moss S, Mukembo S, Alawattegama AB, et al. Treatment of bacterial vaginosis with a three day course of 2% clindamycin vaginal cream: a pilot study. Genitourin Med 1994;70:121-3.
28. Ahmed-Jushuf IH, Shahmanesh M, Arya OP. The treatment of bacterial vaginosis with a 3 day course of 2% clindamycin cream: results of a multicentre, double blind, placebo controlled trial. B V Investigators Group. Genitourin Med 1995;71:254-6.
29. Sobel J, Peipert JF, McGregor JA, Livengood C, Martin M, Robbins J, et al. Efficacy of clindamycin vaginal ovule (3-day treatment) vs. clindamycin vaginal cream (7-day treatment) in bacterial vaginosis. Infect Dis Obstet Gynecol 2001;9:9-15.
30. McCormack WM, Covino JM, Thomason JL, Eschenbach DA, Mou S, Kapernick P, et al. Comparison of clindamycin phosphate vaginal cream with triple sulfonamide vaginal cream in the treatment of bacterial vaginosis. Sex Transm Dis 2001;28:569-75.
31. Paavonen J, Mangioni C, Martin MA, Wajszczuk CP. Vaginal clindamycin and oral metronidazole for bacterial vaginosis: a randomized trial. Obstet Gynecol 2000;96:256-60.
32. Greaves WL, Chungafung J, Morris B, Haile A, Townsend JL. Clindamycin versus metronidazole in the treatment of bacterial vaginosis. Obstet Gynecol 1988;72:799-802.
33. Ugwumadu A, Reid F, Hay P, Manyonda I. Natural history of bacterial vaginosis and intermediate flora in pregnancy and effect of oral clindamycin. Obstet Gynecol 2004;104:114-9.
34. Hillier SL, Lipinski C, Briselden AM, Eschenbach DA. Efficacy of intravaginal 0.75% metronidazole gel for the treatment of bacterial vaginosis. Obstet Gynecol 1993;81:963-7.
35. Livengood CH 3rd, McGregor JA, Soper DE, Newton E, Thomason JL. Bacterial vaginosis: efficacy and safety of intravaginal metronidazole treatment. Am J Obstet Gynecol 1994;170:759-64.
36. Soper DE, Livengood C, Sheehan KL, Fenner DE, Martens MG, Nelson AL, et al. Safety and efficacy comparison of two dosing regimens of MetroGel-Vaginal(R) in the treatment of bacterial vaginosis: a multicenter, randomized, single-blind, parallel comparison. Prim Care Update Ob Gyns 1998;5:150.
37. Livengood CH 3rd, Soper DE, Sheehan KL, Fenner DE, Martens MG, Nelson AL, et al. Comparison of once-daily and twice-daily dosing of 0.75% metronidazole gel in the treatment of bacterial vaginosis. Sex Transm Dis 1999;26:137-42.
38. Hanson JM, McGregor JA, Hillier SL, Eschenbach DA, Kreutner AK, Galask RP, et al. Metronidazole for bacterial vaginosis. A comparison of vaginal gel vs. oral therapy. J Reprod Med 2000;45:889-96.
39. Schwebke JR. Asymptomatic bacterial vaginosis: response to therapy. Am J Obstet Gynecol 2000;183:1434-9.
40. Sanchez S, Garcia PJ, Thomas KK, Catlin M, Holmes KK. Intravaginal metronidazole gel versus metronidazole plus nystatin ovules for bacterial vaginosis: a randomized controlled trial. Am J Obstet Gynecol 2004;191:1898-906.
41. Bistoletti P, Fredricsson B, Hagstrom B, Nord CE. Comparison of oral and vaginal metronidazole therapy for nonspecific bacterial vaginosis. Gynecol Obstet Invest 1986;21:144-9.
42. Ozyurt E, Toykuliyeva MB, Danilyans IL, Morton O, Baktir G. Efficacy of 7-day treatment with metronidazole+miconazole (Neo-Penotran) - a triple-active pessary for the treatment of single and mixed vaginal infections. Int J Gynaecol Obstet 2001;74:35-43.
43. Voorspoels J, Casteels M, Remon JP, Temmerman M. Local treatment of bacterial vaginosis with a bioadhesive metronidazole tablet. Eur J Obstet Gynecol Reprod Biol 2002;105:64-6.
44. Ferris DG, Litaker MS, Woodward L, Mathis D, Hendrich J. Treatment of bacterial vaginosis: a comparison of oral metronidazole, metronidazole vaginal gel, and clindamycin vaginal cream. J Fam Pract 1995;41:443-9.
45. Beigi RH, Austin MN, Meyn LA, Krohn MA, Hillier SL. Antimicrobial resistance associated with the treatment of bacterial vaginosis. Am J Obstet Gynecol 2004;191:1124-9.
46. Colli E, Landoni M, Parazzini F. Treatment of male partners and recurrence of bacterial vaginosis: a randomised trial. Genitourin Med 1997;73:267-70.
47. Potter J. Should sexual partners of women with bacterial vaginosis receive treatment? Br J Gen Pract 1999;49:913-8.
48. Larsson PG, Bergström M, Forsum U, Jacobsson B, Strand A, Wölner-Hanssen P. Bacterial vaginosis. Transmission, role in genital tract infection and pregnancy outcome: an enigma. Review III. APMIS 2005;113:233-45.
49. Barbes C, Boris S. Potential role of lactobacilli as prophylactic agents against genital pathogens. AIDS Patient Care STDS 1999;13:747-51.
50. Hallen A, Jarstrand C, Pahlson C. Treatment of bacterial vaginosis with lactobacilli. Sex Transm Dis 1992;19:146-8.
51. Reid G, Charbonneau D, Erb J, Kochanowski B, Beuerman D, Poehner R, et al. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbiol 2003;35:131-4.
52. Eriksson K, Carlsson B, Forsum U, Larsson PG. A double blind treatment study of bacterial vaginosis with normal vaginal lactobacilli after an open treatment with vaginal clindamycin ovules. Acta Derm Venereol 2005;85:42-6.
53. Antonio MA, Hillier SL. DNA fingerprinting of Lactobacillus crispatus strain CTV-05 by repetitive element sequence-based PCR analysis in a pilot study of vaginal colonization. J Clin Microbiol 2003;41:1881-7.
54. Ozkinay E, Terek MC, Yayci M, Kaiser R, Grob P, Tuncay G. The effectiveness of live lactobacilli in combination with low dose oestriol (Gynoflor) to restore the vaginal flora after treatment of vaginal infections. BJOG 2005;112:234-40.
55. Andersch B, Forssman L, Lincoln K, Torstensson P. Treatment of bacterial vaginosis with an acid cream: a comparison between the effect of lactate-gel and metronidazole. Gynecol Obstet Invest 1986;21:19-25.
56. Andersch B, Lindell D, Dahlen I, Brandberg A. Bacterial vaginosis and the effect of intermittent prophylactic treatment with an acid lactate gel. Gynecol Obstet Invest 1990;30:114-9.
57. Andreeva P, Slavchev B, Kovachev S, Nacheva A, Vacheva R. [Treatment of bacterial vaginosis with high dosage metronidazole and lactic acid]. Akush Ginekol (Sofiia) 2002;41:36-9.
58. Milani M, Barcellona E, Agnello A. Efficacy of the combination of 2 g oral tinidazole and acidic buffering vaginal gel in comparison with vaginal clindamycin alone in bacterial vaginosis: a randomized, investigator-blinded, controlled trial. Eur J Obstet Gynecol Reprod Biol 2003;109:67-71.
59. Harwell JI, Moench T, Mayer KH, Chapman S, Rodriguez I, Cu-Uvin S. A pilot study of treatment of bacterial vaginosis with a buffering vaginal microbicide. J Womens Health (Larchmt) 2003;12:255-9.
60. Platz-Christensen JJ, Pernevi P, Hagmar B, Andersson E, Brandberg A, Wiqvist N. A longitudinal follow-up of bacterial vaginosis during pregnancy. Acta Obstet Gynecol Scand 1993;72:99-102.
61. Hay PE, Morgan DJ, Ison CA, Bhide SA, Romney M, McKenzie P, et al. A longitudinal study of bacterial vaginosis during pregnancy. Br J Obstet Gynaecol 1994;101:1048-53.
62. Boris J, Henriksen TH, Davidsen U, Secher NJ. Evaluation of specific symptoms of bacerial vaginosis among pregnant women. J Infect Dis Obstet Gynecol 1997;5:361-5.
63. Klebanoff MA, Hauth JC, Macpherson CA, Carey JC, Heine RP, Wapner RJ, et al. Time course of the regression of asymptomatic bacterial vaginosis in pregnancy with and without treatment. Am J Obstet Gynecol 2004;190:363-70.
64. Kurkinen-Raty M, Vuopala S, Koskela M, Kekki M, Kurki T, Paavonen J, et al. A randomised controlled trial of vaginal clindamycin for early pregnancy bacterial vaginosis. Bjog 2000;107:1427-32.
65. Bump RC, Zuspan FP, Buesching WJ 3rd, Ayers LW, Stephens TJ. The prevalence, six-month persistence, and predictive values of laboratory indicators of bacterial vaginosis (nonspecific vaginitis) in asymptomatic women. Am J Obstet Gynecol 1984;150:917-24.
66. Mengel MB, Berg AO, Weaver CH, Herman DJ, Herman SJ, Hughes VL, Koepsell TD. The effectiveness of single-dose metronidazole therapy for patients and their partners with bacterial vaginosis. J Fam Pract 1989;28:163-71.
67. Heikkinen J, Vuopala S. Anaerobic vaginosis: treatment with tinidazole vaginal tablets. Gynecol Obstet Invest 1989;28:98-100.
68. Nygaard OG, Csango PA, Jagars G. Treatment in general practice of bacterial vaginosis associated with Mobiluncus species (English abstract). Tidsskr Nor Lægeforen 1991;111:845-7.
69. Moi H, Erkkola R, Jerve F, Nelleman G, Bymose B, Alaksen K, et al. Should male consorts of women with bacterial vaginosis be treated? Genitourin Med 1989;65:263-8.
70. Sobel JD, Schmitt C, Meriwether C. Long-term follow-up of patients with bacterial vaginosis treated with oral metronidazole and topical clindamycin [letter]. J Infect Dis 1993;167:783-4.
71. Wathne B, Holst E, Hovelius B, Mardh PA. Erythromycin versus metronidazole in the treatment of bacterial vaginosis. Acta Obstet Gynecol Scand 1993;72:470-4.
72. Friedman M, Talmon R, Itskovitz-Eldor J. Bacterial vaginoisis: assessment of short and long-term results of treatment by clindamycin versus metronidazole. Cervix Lower Genital Tract Infect 1994;11:157-60.
73. Boris J, Pahlson C, Larsson PG. Six years observation after successful treatment of bacterial vaginosis. J Infect Dis Obstet Gynecol 1997;5:297-302.
74. Wilson J. Managing recurrent bacterial vaginosis. Sex Transm Infect 2004;80:8-11.
75. Cook RL, Redondo-Lopez V, Schmitt C, Meriwether C, Sobel JD. Clinical, microbiological, and biochemical factors in recurrent bacterial vaginosis. J Clin Microbiol 1992;30:870-7.
76. Hay PE. Recurrent bacterial vaginosis. Dermatol Clin 1998;16:769-73, xii-xiii.
77. Hay P. Recurrent Bacterial Vaginosis. Curr Infect Dis Rep 2000;2:506-12.
78. Mengel MB, Davis AB. Recurrent bacterial vaginosis: association with vaginal sponge use. Fam Pract Res J 1992;12:283-8.
79. Tepper RS, Ives TJ, Kebede M. Recurrent bacterial vaginosis unresponsive to metronidazole: successful treatment with oral clindamycin. J Am Board Fam Pract 1994;7:431-2.
80. Bannatyne RM, Smith AM. Recurrent bacterial vaginosis and metronidazole resistance in Gardnerella vaginalis. Sex Transm Infect 1998;74:455-6.
81. Winceslaus SJ, Calver G. Recurrent bacterial vaginosis-an old approach to a new problem. Int J STD AIDS 1996;7:284-7.
82. Cardone A, Zarcone R, Borrelli A, Di Cunzolo A, Russo A, Tartaglia E. Utilisation of hydrogen peroxide in the treatment of recurrent bacterial vaginosis. Minerva Ginecol 2003;55:483-92.
83. Papanikolaou EG, Tsanadis G, Dalkalitsis N, Lolis D. Recurrent bacterial vaginosis in a virgin adolescent: a new method of treatment. Infection 2002;30:403-4.
84. Van Kessel K, Assefi N, Marrazzo J, Eckert L. Common complementary and alternative therapies for yeast vaginitis and bacterial vaginosis: a systematic review. Obstet Gynecol Surv 2003;58:351-8.
85. Pattman RS, Sankar KN, Watson PG, Wardropper AG. An audit of Gynatren (a Lactobacillus acidophilus lyophilisate) vaccination in women with recurrent bacterial vaginosis. Int J STD AIDS 1994;5:299.
86. Plourd DM. Practical Guide to Diagnosing and Treating Vaginitis. Medscape Women's Health 1997;2:2.
87. Nicholls S, Patel HC, Jones M. Recurrent bacterial vaginosis and Netherton's syndrome. Int J STD AIDS 1999;10:202-3.
88. Hudson MM, Tidy JA, McCulloch TA, Rogstad KE. When is bacterial vaginosis not bacterial vaginosis?-a case of cervical carcinoma presenting as recurrent vaginal anaerobic infection. Genitourin Med 1997;73:306-7.
89. Alfonsi GA, Shlay JC, Parker S. What is the best approach for managing recurrent bacterial vaginosis? J Fam Pract 2004;53:650-2; discussion 2.
90. Kane KY, Pierce R. What are the most effective treatments for bacterial vaginosis in nonpregnant women? J Fam Pract 2001;50:399-400.
91. Treatment of BV. Sexually transmitted diseases treatment guidelines 2002. Centers for Disease Control and Prevention. MMWR 2002;51:43.
92. Andreeva PM, Omar HA. Effectiveness of current therapy of bacterial vaginosis. Int J Adolesc Med Health 2002;14:145-8.
93. Koumans EH, Markowitz LE, Hogan V. Indications for therapy and treatment recommendations for bacterial vaginosis in nonpregnant and pregnant women: a synthesis of data. Clin Infect Dis 2002;35:S152-72.
94. National guideline for the management of bacterial vaginosis. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases). Sex Transm Infect 1999;75 Suppl 1:S16-8.
95. McDonald HM, O'Loughlin JA, Vigneswaran R, Jolley PT, McDonald PJ. Bacterial vaginosis in pregnancy and efficacy of short-course oral metronidazole treatment: a randomized controlled trial. Obstet Gynecol 1994;84:343-8.
96. Hauth JC, Goldenberg RL, Andrews WW, DuBard MB, Copper RL. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N Engl J Med 1995;333:1732-6.
97. McGregor JA, French JI, Parker R, Draper D, Patterson E, Jones W et al. Prevention of premature birth by screening and treatment for common genital tract infections: results of a prospective controlled evaluation. Am J Obstet Gynecol 1995;173:157-67.
98. Joesoef MR, Hillier SL, Wiknjosastro G, Sumampouw H, Linnan M, Norojono W, et al. Intravaginal clindamycin treatment for bacterial vaginosis: effects on preterm delivery and low birth weight. Am J Obstet Gynecol 1995;173:1527-31.
99. McDonald HM, O'Loughlin JA, Vigneswaran R, Jolley PT, Harvey JA, Bof A, et al. Impact of metronidazole therapy on preterm birth in women with bacterial vaginosis flora (Gardnerella vaginalis): a randomised, placebo controlled trial. Br J Obstet Gynaecol 1997;104:1391-7.
100. Yudin MH, Landers DV, Meyn L, Hillier SL. Clinical and cervical cytokine response to treatment with oral or vaginal metronidazole for bacterial vaginosis during pregnancy: a randomized trial. Obstet Gynecol 2003;102:527-34.